TY  - GEN
AU  - Valenciano, Marta
AU  - Kissling, Esther
AU  - Reuss, Annicka
AU  - Jimenez-Jorge, Silvia
AU  - Horváth, Judit Krisztina
AU  - Donnell, Joan M O
AU  - Pitigoi, Daniela
AU  - Machado, Ausenda
AU  - Pozo Sanchez, Francisco
AU  - I-MOVE Multicentre Case Control Study Team
PY  - 2015
DO  - 10.1016/j.vaccine.2015.04.012
UR  - http://hdl.handle.net/20.500.12105/11439
AB  - Background: In the first five I-MOVE (Influenza Monitoring Vaccine Effectiveness in Europe) influenza seasons vaccine effectiveness (VE) results were relatively homogenous among participating study sites. In 2013-2014, we undertook a multicentre...
LA  - eng
PB  - Elsevier
KW  - Influenza vaccine
KW  - Influenza vaccine effectiveness
KW  - Multicentre study
KW  - Test-negative design
KW  - Vaccine effectiveness
KW  - Vaccine Potency
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Case-Control Studies
KW  - Child
KW  - Child, Preschool
KW  - Europe
KW  - European Union
KW  - Female
KW  - Humans
KW  - Infant
KW  - Infant, Newborn
KW  - Influenza A Virus, H1N1 Subtype
KW  - Influenza A Virus, H3N2 Subtype
KW  - Influenza Vaccines
KW  - Influenza, Human
KW  - Male
KW  - Middle Aged
KW  - Odds Ratio
KW  - Seasons
KW  - Sentinel Surveillance
KW  - Time Factors
KW  - Vaccination
TI  - The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
TY  - research article
ER  -